Why the study?
Do pharmacological interventions improve anxiety symptoms and other clinical outcomes in patients >40 years old with COPD and co-existing anxiety disorders?
Do pharmacological interventions improve anxiety symptoms and other clinical outcomes in patients >40 years old with COPD and co-existing anxiety disorders?
There is currently insufficient high-quality evidence to determine the efficacy of pharmacological interventions for anxiety disorders in patients with COPD.
No takes yet. Share an insight, caveat, or question.
Insufficient evidence precludes guiding anxiety treatment in COPD; leaves open efficacy of pharmacological interventions pending better trials.
Usmani et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: